Navigation Links
Present in Biological Technology

InterMune to Present at Canaccord Adams Conference

BRISBANE, Calif., Aug. 7 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN ) today announced that Dan Welch, Chairman, Chief Executive Officer and President of InterMune, will present at the Canaccord Adams 29th Annual Global Growth Conference in Boston on August 12, 2009 at 10:3...

AEterna Zentaris to Present at Upcoming Canaccord Adams 29th Annual Global Growth Conference

QUEBEC CITY, Aug. 6 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: AEZS , TSX: AEZ), a global biopharmaceutical company focused on endocrine therapy and oncology, today announced that its President and CEO, Juergen Engel, Ph.D., will present a corporate overview at the upcoming Canaccor...

Pharmasset to Present at Canaccord Adams Conference

PRINCETON, N.J., Aug. 5 /PRNewswire-FirstCall/ -- Pharmasset, Inc. (Nasdaq: VRUS ) announces management will present at the Canaccord Adams 29(th) Annual Global Growth Conference in Boston, MA. Schaefer Price, Pharmasset's President and Chief Executive Officer, will provide a...

VIVUS to Present at the Canaccord Adams 29th Annual Global Growth Conference

MOUNTAIN VIEW, Calif., Aug. 4 /PRNewswire-FirstCall/ -- VIVUS, Inc. (Nasdaq: VVUS ), a pharmaceutical company dedicated to the development and commercialization of novel therapeutic products, today announced that Timothy Morris, chief financial officer, will present an overview of the ...

Optimer Pharmaceuticals to Present at the Canaccord Adams 29th Annual Global Growth Conference

SAN DIEGO, Aug. 4 /PRNewswire-FirstCall/ -- Optimer Pharmaceuticals, Inc. (Nasdaq: OPTR ) is scheduled to present at the Canaccord Adams 29th Annual Global Growth Conference at the Intercontinental Hotel in Boston on August 13, 2009, 2:00 p.m. Eastern Time. (Logo: http://w...

Nektar Therapeutics to Present at the BMO Capital Markets 9th Annual Focus on Healthcare Conference in New York City

SAN CARLOS, Calif., July 31 /PRNewswire-FirstCall/ -- Nektar Therapeutics (Nasdaq: NKTR ) is scheduled to present at the upcoming BMO Capital Markets 9th Annual Focus on Healthcare Conference at the Millennium Broadway Hotel in New York City on Wednesday, August 5, 2009 at 1:45 p.m. ...

Stemline Therapeutics CEO to Present at IBC's New Frontiers in Cancer Drug Development Conference

NEW YORK, July 30 /PRNewswire/ -- Stemline Therapeutics, Inc., a clinical stage biopharmaceutical company and a leading developer of oncology compounds directed to cancer stem cell targets, today announced that the Company's CEO, Ivan Bergstein M.D. has been invited to present at the New Fron...

PDL BioPharma to Present at BMO Capital Markets Healthcare Conference on August 5, 2009

INCLINE VILLAGE, Nev., July 29 /PRNewswire-FirstCall/ -- PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI ) today announced that John P. McLaughlin, the company's president and chief executive officer, will present at the BMO Capital Markets Healthcare Conference in New York City on Wednes...

Patent Awarded for a New X-ray Imaging Technology with Capability Unrealized with Present Day Radiological Modalities

Now, a newly patented x-ray microscope technology makes it possible to see every wire in a stent, magnified 25 times larger than actual size, as clearly as if it were being viewed through a microscope, while exposing the animal and researcher to significantly less radiation than current FDA dosa...

NovaBay(R) Pharmaceuticals to Present at Jesup & Lamont 2009 Growth Stock Conference

EMERYVILLE, Calif., July 27 /PRNewswire-FirstCall/ -- NovaBay(R) Pharmaceuticals, Inc. (NYSE-AMEX: NBY ) ( http://www.novabaypharma.com ), a clinical stage company developing non-antibiotic anti-infective compounds for the treatment or prevention of a wide range of bacterial,...

Neurocrine Biosciences Announces Conference Call and Webcast to Present Second Quarter 2009 Financial Results

SAN DIEGO, July 23 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) announced today that the Company will report its second quarter 2009 financial results after the Nasdaq market closes on Wednesday, July 29, 2009. Neurocrine will then host a live con...

Peregrine Pharmaceuticals to Present at the Jesup & Lamont 2009 Growth Stock & National Sales Conference

TUSTIN, Calif., July 23 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM ) today announced that senior management will present at the Jesup & Lamont 2009 Growth Stock & National Sales Conference on Thursday, July 30, 2009 at 8:30 am EDT at the Boca Raton ...

Vistaar and the Professional Pricing Society Partner to Present Premier Symposium for Pricing Practitioners

Renowned pricing expert and industry thought leader Dr. Reed Holden to present the keynote address Parsipany, NJ (PRWEB) July 22, 2009 -- Vistaar Technologies, Inc. Vistaar Technologies, a leading provider of pricing software for sales, marketing and finance groups, t...

BioSpecifics Technologies Corp. to Present at CapStone Investments' Third Annual Small-Cap Investor Conference

LYNBROOK, N.Y., July 22 /PRNewswire-FirstCall/ -- BioSpecifics Technologies Corp. (Nasdaq: BSTC ), a biopharmaceutical company developing first in class collagenase-based products, today announced that BioSpecifics' President, Tom Wegman, will present at the upcoming CapStone Inve...

Oncolytics Biotech(R) Inc. Research Collaborators Present Glioma Reovirus Research at ASV Annual Meeting

CALGARY, July 15 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY ) announced today that a poster presentation by Dr. Jacqueline Parker et al. entitled "Anti-Tumor Activity of Reovirus is Synergistically Enhanced in Combination with Temozolomide and Low Dose Irradiation i...

Helix BioPharma to Present L-DOS47 Analytical Method Development Findings at 2009 AAPS National Biotechnology Conference

AURORA, Ontario, June 19 /PRNewswire-FirstCall/ -- Helix BioPharma Corp. (TSX, FSE: HBP) today announced that Dr. Heman Chao, chief scientific officer at Helix BioPharma Corp., will be presenting a scientific poster describing L-DOS47 analytical method development findings at the 2009 American Ass...

Novavax CEO to Present at Phacilitate Vaccine Forum Barcelona 2009

ROCKVILLE, Md., June 18 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX ) a clinical-stage vaccine company, announced today that Dr. Rahul Singhvi, President and Chief Executive Officer, will be presenting at the Phacilitate Vaccine Forum Barcelona 2009 conference on June 22 and June 23, 2...

Amylin Pharmaceuticals to Present at Piper Jaffray Europe Conference

SAN DIEGO, June 17 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ) will be presenting at the Piper Jaffray Europe Conference in London on Wednesday, June 24, 2009 at 10:30 a.m. British Summer Time/ 5:30 a.m. ET. Daniel M. Bradbury, president and chief executive officer o...

PAREXEL International to Present at the Wachovia Equity Conference

BOSTON, June 17 /PRNewswire-FirstCall/ -- PAREXEL International Corporation (Nasdaq: PRXL ) announced today it will be presenting at the Wachovia 19th Annual Mid-Year Equity Conference in Boston. James Winschel, Senior Vice President & Chief Financial Officer will be making a formal present...

Covance to Present at the Drug Information Association's 45th Annual Meeting

- Covance experts to present best practices for improving drug safety and reducing R&D time, cost - PRINCETON, N.J., June 16 /PRNewswire-FirstCall/ -- Covance Inc. is pleased to announce the complete list of experts scheduled to present at the Drug Information Association's (DIA) 45th A...

WuXi PharmaTech to Present at Third Annual Jefferies Healthcare Conference

SHANGHAI, June 16 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX ) today announced that Edward Hu, the Company's Chief Operating Officer and acting Chief Financial Officer, will present at the Third Annual Jefferies Healthcare Conference in New York on Wednesday, June 17, 2009,...

Sunesis to Present at the Jefferies 3rd Annual Healthcare Conference

SOUTH SAN FRANCISCO, Calif., June 16 /PRNewswire-FirstCall/ -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS ), a biopharmaceutical company focused on the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers, today announced that Daniel ...

Cynvec to Present at The 2009 New York Venture Summit

- Company Selected as a Top Innovator - NEW YORK, June 15 /PRNewswire/ -- Cynvec LLC, a privately held biotechnology company focused on developing novel cancer therapies that harness the apoptotic ability of the sindbis viral vector, today announced that Frank Stonebanks, President and Ch...

PharmaNet Development Group Clinical Research Experts to Present at Global Professional Meetings in June

PRINCETON, N.J., June 10 /PRNewswire/ -- PharmaNet Development Group, Inc., a leading provider of clinical development services to innovative pharmaceutical, biotechnology, generic drug and medical device companies, today announced its participation at several international professional meetings d...

BioMarin to Present at the Jefferies Healthcare Conference

NOVATO, Calif., June 10 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN ) today announced that Steve Aselage, Senior Vice President and Chief Business Officer of BioMarin, will present a company update at the Jefferies Healthcare Conference in New York City on Wednesday, Jun...

Express Scripts to Present at William Blair Growth Stock Conference

ST. LOUIS, June 5 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX ) announced that it will present at the William Blair Growth Stock Conference on Thursday, June 11, 2009 at 8:00 a.m. CT at the Four Seasons Hotel in Chicago. This presentation will also be broadcast via th...

Pharmacyclics to Present at the 8th Annual Needham and Company Life Sciences Conference

SUNNYVALE, Calif., June 5 /PRNewswire-FirstCall/ -- Pharmacyclics, Inc. (Nasdaq: PCYC ), a biopharmaceutical company focused on developing and commercializing innovative small molecule drugs for the treatment of immune mediated disease and cancer, today announced that Glenn Rice, President and C...

Poniard Pharmaceuticals to Present at the 8th Annual Needham Life Sciences Conference

SOUTH SAN FRANCISCO, Calif., June 5 /PRNewswire-FirstCall/ -- Poniard Pharmaceuticals, Inc. (Nasdaq: PARD ), a biopharmaceutical company focused on innovative oncology therapies, today announced that Jerry McMahon, Ph.D., chairman and chief executive officer, will provide a corporate overview at...

Arena Pharmaceuticals to Present at the 8th Annual Needham Life Sciences Conference

SAN DIEGO, June 5, 2009 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA ) announced today that the company is scheduled to present at the 8th Annual Needham Life Sciences Conference on June 11, 2009 at 11:00 a.m. Eastern Time (8:00 a.m. Pacific Time) at the New York Palace ...

Akaza Research to Present and Exhibit at Upcoming DIA Annual Meeting

Akaza Research CEO will be presenting at the upcoming DIA annual meeting. In addition, Akaza Research will be be exhibiting OpenClinica, the popular open source clinical trials software. Cambridge, MA (PRWEB) June 5, 2009 -- Akaza Research is pleased to announce that Ch...

Neurocrine Biosciences to Present at the 8th Annual Needham Life Sciences Conference

LIVE AUDIO WEBCAST WEDNESDAY, JUNE 10, 2009 SAN DIEGO, June 4 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) announced today that Kevin Gorman, President and Chief Executive Officer of Neurocrine Biosciences will be presenting at the 8th Annual Needham Life Sciences...

Optimer Pharmaceuticals to Present at June 2009 Investor Conferences

SAN DIEGO, June 4 /PRNewswire-FirstCall/ -- Optimer Pharmaceuticals, Inc. (Nasdaq: OPTR ) today announced that the Company will present at the following investor conferences: 8th Annual Needham Life Sciences Conference on Wednesday, June 10, 2009 at 9:00 a.m. Eastern Time at t...

Amylin Pharmaceuticals to Present at Goldman Sachs Annual Global Health Care Conference

SAN DIEGO, June 3 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ) will be presenting at the Goldman Sachs Annual Global Health Care Conference on Tuesday, June 9, 2009 at 10:45 a.m. ET / 7:45 a.m. PT in New York. Daniel M. Bradbury, president and chief executive officer...

InterMune to Present at Goldman Sachs Healthcare Conference

BRISBANE, Calif., June 3 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN ) today announced that Daniel Welch, Chairman, Chief Executive Officer and President of InterMune, will present at the Goldman Sachs 30th Annual Global Healthcare Conference in New York on June 9, 2009 at 2:35 p.m. ...

NeurogesX to Present at Needham Life Sciences Conference

SAN MATEO, Calif., June 3 /PRNewswire-FirstCall/ -- NeurogesX, Inc. (Nasdaq: NGSX ), a biopharmaceutical company focused on developing and commercializing novel pain management therapies, announced today that Anthony DiTonno, President and Chief Executive Officer, is scheduled to present at th...

VIVUS to Present at the Needham and Company Life Sciences Conference

MOUNTAIN VIEW, Calif., June 3 /PRNewswire-FirstCall/ -- VIVUS, Inc. (Nasdaq: VVUS ), a pharmaceutical company dedicated to the development and commercialization of novel therapeutic products, today announced that Dr. Barbara Troupin, senior director clinical development, will present an overview...

PAREXEL Experts to Present Leading Insights at Drug Information Association 45th Annual Meeting

BOSTON, June 3 /PRNewswire-FirstCall/ -- Experts from PAREXEL International Corporation (Nasdaq: PRXL ), a leading global biopharmaceutical services provider, will address important industry issues at the Drug Information Association (DIA) 45th Annual Meeting, being held from June 21 - 25, 2009 ...

Clarient to Present at Noble Financial's 5th Annual Equity Conference on Tuesday, June 9th

Presentation Scheduled for 11:35am EDT ALISO VIEJO, Calif., June 3 /PRNewswire-FirstCall/ -- Clarient, Inc. (Nasdaq: CLRT ), a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced that Ron Andrews , CEO and Vice Chairman...

Cynvec to Present at the 11th Annual Shanghai International Forum on Biotechnology and Pharmaceutical Industry

NEW YORK, June 2 /PRNewswire/ -- Cynvec LLC, a privately held biotechnology company focused on developing novel cancer therapies that harness the apoptotic ability of the sindbis viral vector, today announced that Frank Stonebanks, President and Chief Executive Officer, will make a presentation ti...

ViroPharma to Present at Two June Healthcare Conferences

EXTON, Pa., June 2 /PRNewswire-FirstCall/ -- ViroPharma Incorporated (Nasdaq: VPHM ) today announced that Colin Broom, MD, vice president and chief scientific officer of ViroPharma, will present at the 30th Annual Goldman Sachs Global Healthcare Conference at 3:45 P.M. ET on Tuesday, June 9, 200...
Other Tags
(Date:10/31/2014)... and his team have been studying the behavior ... Austrian Alps for years. They observed that ravens ... grooming and playing. However, they also observed that ... third individual. Although in about 50 % of ... up the two affiliating ravens, intervening can be ...
(Date:10/30/2014)... German . ... humans to behave socially? This is one of the ... Previous studies assumed that it is almost impossible to ... Max Planck Institute for Evolutionary Biology have now demonstrated ... the cooperative behaviour of others. However, the possibilities available ...
(Date:10/30/2014)... , Oct. 29, 2014  Securus ... criminal justice technology solutions for public safety, ... it has deployed exciting enhancements to its ... analytics to provide actionable intelligence and focused ... continues to drive technological innovation through identifying ...
Breaking Biology News(10 mins):Together we are strong -- or insufferable 2Together we are strong -- or insufferable 3Together we are strong -- or insufferable 4Securus Technologies Adds Advanced Features to Its Industry-Leading Investigative Analytics Product 2
(Date:10/31/2014)... terms of duration of treatment and cost, patients ... accelerated partial breast irradiation (APBI) with proton therapy ... research from The University of Texas MD Anderson ... cost analysis study based on typical patient characteristics, ... charges for eight different types of partial and ...
(Date:10/31/2014)... 2014 Gold Medal Wine Club ... but tasteful gifts for the wine novice and enthusiasts on ... Gift Giving Special , which Early Bird shoppers receive discounts ... Club Gift membership. , Gift Givers must place their ... Besides offering discounts, Gold Medal Wine Club adds more value ...
(Date:10/31/2014)... scientists have found a drug combination that can trigger ... the way for new treatments, according to research that ... (NCRI) Cancer Conference in Liverpool next week*. , When ... chain of events culminating in self destruction. But cancer ... immortal. This means that cells grow out of control ...
(Date:10/31/2014)... October 31, 2014 Triple Board Certified ... hair restoration services to transform the appearance of military ... American Academy of Facial Plastic and Reconstruction Surgery (AAFPRS) ... to restore the facial hair Jones lost during an ... The pro-bono hair restoration procedure, valued around $16,000, took ...
(Date:10/31/2014)... Radiology and EMR Integration , “Surveys ... diagnostic imaging centers but Connectivity is Opportunity,” says ... “Differentiation is critical in all businesses today and ... the intense competition and the downward pressure on ... from the competition by fully integrating with the ...
Breaking Medicine News(10 mins):Health News:Proton therapy shown to be less costly than some alternative radiotherapy techniques 2Health News:Proton therapy shown to be less costly than some alternative radiotherapy techniques 3Health News:Gold Medal Wine Club now offering Early Bird Gift Giving Special for Holidays 2Health News:Scientists trigger self-destruct switch in lung cancer cells 2Health News:Miami Hair Restoration Specialist Transforms Wounded Soldier 2Health News:Diagnostic Imaging of Salem Expects Growth Partnering with DigitalOne 2
Other Contents